Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 17 10 2019
accepted: 07 01 2020
pubmed: 23 1 2020
medline: 29 1 2021
entrez: 23 1 2020
Statut: epublish

Résumé

The aim was to assess the appropriateness of recommended regimens for empirical MIC coverage in critically ill patients with open-abdomen and negative-pressure therapy (OA/NPT). Over a 5-year period, every critically ill patient who received amikacin and who underwent therapeutic drug monitoring (TDM) while being treated by OA/NPT was retrospectively included. A population pharmacokinetic (PK) modeling was performed considering the effect of 10 covariates (age, sex, total body weight [TBW], adapted body weight [ABW], body surface area [BSA], modified sepsis-related organ failure assessment [SOFA] score, vasopressor use, creatinine clearance [CL

Identifiants

pubmed: 31964795
pii: AAC.02098-19
doi: 10.1128/AAC.02098-19
pmc: PMC7179257
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Amikacin 84319SGC3C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Int J Antimicrob Agents. 2018 Apr;51(4):562-570
pubmed: 29180278
Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):39-46
pubmed: 10412890
Ann Intensive Care. 2016 Dec;6(1):106
pubmed: 27807818
Antimicrob Agents Chemother. 2019 Feb 26;63(3):
pubmed: 30602511
Int J Antimicrob Agents. 2011 Jun;37(6):531-5
pubmed: 21489756
Clin Ther. 2004 Feb;26(2):271-81
pubmed: 15038949
Eur J Clin Pharmacol. 2015 Jan;71(1):75-83
pubmed: 25327505
Intensive Care Med. 2014 Jul;40(7):998-1005
pubmed: 24687298
J Infect Dis. 1987 Jan;155(1):93-9
pubmed: 3540140
Ther Drug Monit. 2010 Dec;32(6):749-56
pubmed: 20962708
Int J Surg. 2014 Oct;12(10):1105-14
pubmed: 25174789
J Glob Antimicrob Resist. 2018 Mar;12:90-95
pubmed: 29017888
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4901-9
pubmed: 27270279
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31481443
Crit Care. 2011 Jun 08;15(3):R139
pubmed: 21651804
Crit Care Med. 1997 May;25(5):806-11
pubmed: 9187600
Crit Care. 2018 Jul 23;22(1):177
pubmed: 30037335
Anaesth Crit Care Pain Med. 2018 Feb;37(1):35-41
pubmed: 28756331
Int J Antimicrob Agents. 2015 Jul;46(1):21-7
pubmed: 25857948
Anaesthesiol Intensive Ther. 2015;47(4):372-8
pubmed: 25973658
J Antimicrob Chemother. 2015 May;70(5):1495-502
pubmed: 25608584
Clin Infect Dis. 2007 Sep 15;45(6):753-60
pubmed: 17712761
Med Mal Infect. 2012 Jul;42(7):301-8
pubmed: 22770656
J Antimicrob Chemother. 1999 Jul;44(1):99-108
pubmed: 10459816
J Antimicrob Chemother. 2016 Jan;71(1):208-12
pubmed: 26429564
Clin Drug Investig. 1998;15(5):435-44
pubmed: 18370499
Int J Antimicrob Agents. 2013 Aug;42(2):155-60
pubmed: 23756322
Antimicrob Agents Chemother. 1996 Jul;40(7):1682-9
pubmed: 8807062
Crit Care. 2010;14(2):R53
pubmed: 20370907
Antimicrob Agents Chemother. 1999 Mar;43(3):623-9
pubmed: 10049277
Fundam Clin Pharmacol. 1995;9(1):57-61
pubmed: 7768489
Pharmacotherapy. 2018 Dec;38(12):1229-1238
pubmed: 30403305
Infect Dis Ther. 2013 Dec;2(2):217-26
pubmed: 25134484
Crit Care. 2013 Jul 25;17(4):R165
pubmed: 23886243
Clin Pharmacokinet. 2017 Feb;56(2):127-138
pubmed: 27324191

Auteurs

Cédric Carrié (C)

Anesthesiology and Critical Care Department, CHU Bordeaux, Bordeaux, France cedric.carrie@chu-bordeaux.fr.

Faustine Delzor (F)

Pharmacokinetics and PK/PD Group, INSERM 1034, University of Bordeaux, Bordeaux, France.
Pharmacy and Clinical Pharmacy Department, CHU Bordeaux, Bordeaux, France.

Stéphanie Roure (S)

Anesthesiology and Critical Care Department, CHU Bordeaux, Bordeaux, France.

Vincent Dubuisson (V)

Department of Vascular and General Surgery, CHU Bordeaux, Bordeaux, France.

Laurent Petit (L)

Anesthesiology and Critical Care Department, CHU Bordeaux, Bordeaux, France.

Mathieu Molimard (M)

Pharmacology and Toxicology Department, CHU Bordeaux, Bordeaux, France.
University of Bordeaux Segalen, Bordeaux, France.

Dominique Breilh (D)

Pharmacokinetics and PK/PD Group, INSERM 1034, University of Bordeaux, Bordeaux, France.
Pharmacy and Clinical Pharmacy Department, CHU Bordeaux, Bordeaux, France.

Matthieu Biais (M)

Anesthesiology and Critical Care Department, CHU Bordeaux, Bordeaux, France.
University of Bordeaux Segalen, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH